Corporate Profile  

Target Market 
 

Business Strategy
Our Story

Chairman's Message

Co-Founder's Message

Mission Statement

Officers & Key Personnel

Scientific Advisory Board

   
Officers & Key Personnel  
 

 

Daniel C. Montano
Co-Founder, Chairman of the Board, President,
Chief Executive Officer

 

Thomas J. Stegmann, M.D., Ph.D.
Co-Founder, Chief Medical Officer

 

Mickael A. Flaa
Vice President, Chief Financial Officer

 

John (Jack) William Jacobs, Ph.D.
Vice President, Chief Scientific Officer and Chief Operating Officer

 

Kenneth A. Thomas, Ph.D.
Vice President, Research and Development


Our management team is aided and supported by an outstanding group of employees, consultants, advisors, associates and clinical personnel, all of whom play a vital role in CVBT’s overall success.

 

 


 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement


5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial


4/24/2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership